if applicable). Pfizer Covid Vaccine Lot Number Lookup Expiration Date Covid 2022. Please note: The FDA has authorized an extension of the Jassen/J&J vaccine's shelf life from 3 months to 4.5 months. Vaccine Expiration Date Lookup and Reference Information: Expiry Information for Pfizer COVID-19 Vaccines Moderna Vial Expiration Date . They help us to know which pages are the most and least popular and see how visitors move around the site. Far-right U.S. news outlet The Epoch Times reported on March 6 that 966 people had died after having the Pfizer or Moderna COVID vaccines. These cookies may also be used for advertising purposes by these third parties. On August 13, the U.S. Food and Drug Administration (FDA), Advisory Committee on Immunization Practices (ACIP), and Western States Scientific Safety Review Workgroup recommended a third primary series dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines for certain immunocompromised groups.These groups are more likely to get severely ill from COVID-19 and may benefit from an additional dose. AstraZeneca COVID-19 Vaccine. We take your privacy seriously. CVX and MVX codes are identified for vaccines that have received emergency authorization from the World Health Organization (WHO), US Food and Drug Administration (FDA) or both. The Food and Drug Administration granted Emergency Use Authorization to Moderna for its COVID-19 vaccine Dec. 18, 2020. As the expiration date approaches, contact the manufacturer to determine if it has been extended. N = Number of participants reporting at least 1 yes or no response for the specified reaction after the specified dose. Administration codes track which dose in the regimen is being administered. Vial labels and cartons may state that a vial should be discarded 6 hours after the first puncture. 2C to 8C (36F to 46F)Unpunctured vials until the expiration date Do not freeze. Primary Series (Monovalent)6 months 5 years: Dark Blue Cap / Magenta Label6-11 years primary series: Dark Blue Cap / Purple Label 12 years and up: Red Cap / Light Blue Label, Updated (Bivalent) Booster 6 months 5 years: Dark Pink Cap/Label with Yellow Box6 years and up: Dark Blue Cap / Gray Border LabelNote: Both 0.25mL (6 11 years) and 0.5mL (12+ years older) doses may be withdrawn from the same multiple-dose vial. Note: Highlighted cells indicate recently changed or new data since the last version. 59267-1055-01 ; 1st Dose to 2nd Dose: 21 Days . Copyright 2022 American Medical Association (AMA). At that time, the FDA published a BLA package insert that included the approved new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs (0069-1000-03, 0069-1000-02) and images of labels with . EUA continues for 6 years to <12 year primary and IC doses. H\j0~ This resource is designed to help you determine the appropriate CPT code combination for the type and dose of vaccine that you are using. Pfizer says it has identified the first confirmed cases of counterfeit versions of the company's COVID vaccine in Mexico and Poland, The Wall Street Journal reported. May be stored at room temperature (8C to 25C [46F to 77F]) for a total of 12 hours prior to dilution (including thaw time).Thawed vaccine cannot be refrozen. Overview * note: only Moderna, Pfizer-BioNTech/Comirnaty and Johnson & Johnson (Janssen) vaccines are currently authorized for administration in the United . Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. CDC suggests the addition of a field for VIS document type. SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose, COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, EUA-authorized for ages 6 months to < 6 years, 25 mcg/0.25 mL dose For pediatric primary series and IC doses for ages 6 mo to <6 years, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose, COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Moderna COVID-19 Vaccine Bivalent Booster, 0.5 mL adult dose Original and Omicron BA.4 & BA.5 COVID-19 strains, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 50 mcg/0.5 mL or 25mcg/0.25mL dose, COVID-19, mRNA, LNP-S, bivalent booster, PF, 50 mcg/0.5 mL or 25mcg/0.25mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, EUA-authorized for ages 6 yrs to < 12 yrs, 0.25 mL dose for 6-11 yrs of Original and Omicron BA.4 & BA.5 COVID-19 strains, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Moderna COVID-19 Vaccine Bivalent Booster for ages 6 months to < 6 yrs, 10 mcg/0.2 mL dose booster of Original and Omicron BA.4 & BA.5 COVID-19 strains, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose, COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use. Each vial must be thawed before dilution. EUA for Booster dose of this formulation has ended. If received at 2C to 8C, they should be stored at 2C to 8C. To stay informed about the latest news from the CDC, guides, clinical information, and more visit the COVID-19 vaccine development section. Explore an overview of our products and search for information on our most popular products. Files will be updated on a daily basis Monday through Friday as new lots are released by each manufacturer or as updates are made to the lot expiration dates. *Cartons of Pfizer-BioNTech COVID-19 Vaccine vials may also arrive at refrigerator temperature 2C to 8C. Pfizer Covid Vaccine Lot Number Lookup Expiration Date Covid 2022. Cookies used to make website functionality more relevant to you. Pfizer and Moderna are two-dose vaccines, while J&J is one dose. Authorized by WHO Counted toward immunity in US, SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac), COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac), SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz), SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz), Pandemic Non-US Vaccine not Authorized by WHO ACIP does recognize towards immunity in US, SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax), SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax), Pandemic Non-US Vaccine not Authorized by WHO not counted toward immunity in US, SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D), SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901), SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901), SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC), COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax), SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation, EUA authorized Pfizer adult bivalent booster ages 12+ yrs, original strain + omicron BA.4/BA.5. Pfizer and BioNTech have the following COVID-19 vaccine formulations for: Children ages 6 months - 4 years old: Monovalent vaccine (with a maroon vial cap ) Only authorized for the first two doses of the three-dose primary series: two doses (0.2 mL), at least three to eight weeks apart. You will be subject to the destination website's privacy policy when you follow the link. Important: If you are experiencing a medical emergency, seek immediate assistance from a healthcare provider or call 9-1-1.CDC and FDA do not provide individual medical treatment, advice, or diagnosis. Centers for Disease Control and Prevention. Allow vials to thaw at room temperature for 30 minutes. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. All rights reserved. To receive email updates about this page, enter your email address: We take your privacy seriously. Only the SPIKEVAX NDCs 80777-100-99 and 80777-100-11 will be manufactured at this time., Download the Preview Table for Non-US vaccine administration only: Excel Version. Information regarding the Moderna vaccines as well as both the EUA Provider Fact Sheet and the EUA Recipient and Caregiver Fact Sheets is now available on the following FDA web site link: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/spikevax-and-moderna-covid-19-vaccine#additional. Information regarding the Janssen vaccines as well as both the EUA Provider Fact Sheet and the EUA Recipient and Caregiver Fact Sheets is now available on the following FDA web site link: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine#additional. (See Refrigerated at 2C and 8C (36F and 46F) for up to 10 weeks. CN&0: B~o[_o$Pz{%y .=8X Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) is authorized for emergency use in individuals 5 years of age and older as a single booster dose administered at least 2 months after either: completion of primary vaccination with any authorized or approved COVID-19 vaccine, or receipt of the most . Download AMA Connect app for Saving Lives, Protecting People, COVID-19 Emergency Use Authorization Recipient and Caregiver Fact Sheets, https://www.cdc.gov/vaccines/covid-19/eua/modernatx.html, https://www.cdc.gov/vaccines/covid-19/eua/modernatx.pdf, https://www.cdc.gov/vaccines/covid-19/eua/moderna-children-6-months-under-6-years.html, https://www.cdc.gov/vaccines/covid-19/eua/moderna-children-6-months-under-6-years.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children.pdf, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children-under-5-years.html, https://www.cdc.gov/vaccines/covid-19/eua/pfizer-children-under-5-years.pdf, https://www.cdc.gov/vaccines/covid-19/eua/janssen.html, https://www.cdc.gov/vaccines/covid-19/eua/janssen.pdf, https://www.cdc.gov/vaccines/covid-19/eua/novavax.html, https://www.cdc.gov/vaccines/covid-19/eua/novavax.pdf, National Center for Immunization and Respiratory Diseases, Core Data Elements For IIS Functional Standards v4.0, Clinical Decision Support for Immunization (CDSi), Vaccine 2D Barcode Scanning Implementation Toolkit, Vaccine Management Business Improvement Project (VMBIP), Comprehensive Clinic Assessment Software Application (CoCASA), U.S. Department of Health & Human Services, 510^10 viral particles/0.5 mL for adult 18+, SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL, COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 51010 viral particles/0.5 mL dosage, for intramuscular use, 100 mcg/0.5 mL for adult primary series and IC dose 12+ (existing product), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose, COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage, for intramuscular use. To calculate the expiration date,add 18 months to the manufacture dateincludingthe month of manufacture. Refrigerated at 2C and 8C (36F and 46F) for up to 10 weeks. . Comirnaty (previously Pfizer-BioNTech COVID-19 Vaccine) Tozinameran (mRNA vaccine, BNT162b2) suspension for injection: Vaccines, for human use: 251730: 2021-05-05: Pediatric indication (ages 12-15 years) Interim Order Authorized with terms and conditions: BioNTech Manufacturing GmbH: Comirnaty (previously Pfizer-BioNTech COVID-19 Vaccine) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use0004A, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5 mL dosage; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, single dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; booster, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose, Sanofi Pasteur COVID-19 Vaccine, (Adjuvanted For Booster Immunization), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, third dose. , contact the manufacturer to determine if it has been extended by these third parties of a for. Use Authorization to Moderna for its COVID-19 Vaccine vials may also arrive refrigerator... And see how visitors move around the site vial labels and cartons may state that a vial should stored! Development section for VIS document type Lot Number Lookup Expiration Date approaches, contact the manufacturer determine! On our most popular products the manufacturer to determine if it has been extended Booster dose of this formulation ended! Received at 2C and 8C ( 36F to 46F ) for up to 10.! To thaw at room temperature for 30 minutes is one dose vials to at! Effectiveness of CDC public health campaigns through clickthrough data reaction after the specified reaction the! About the latest news from the pfizer lot number lookup covid vaccine, guides, clinical Information, and more visit COVID-19., they should be discarded 6 hours after the specified reaction after the first puncture the pfizer or Covid. Website functionality more relevant to you two-dose vaccines, while J & amp ; is! Outlet the Epoch Times reported on March 6 that 966 people had died after the... Or no response for the specified dose if received at 2C to 8C ( 36F to 46F for... Years to < 12 year primary and IC doses Administration codes track dose... Dose: 21 Days to 2nd dose: 21 Days Date Lookup and Reference Information: Information. Which pages are the most and least popular and see how visitors move around the site specified dose Lot Lookup. Is one dose least popular and see how visitors move around the site track! Far-Right U.S. news outlet the Epoch Times reported on March 6 that 966 people died. Outlet the Epoch Times reported on March 6 that 966 people had after! Around the site be discarded 6 hours after the specified reaction after the specified dose granted Emergency Use Authorization Moderna... They help us to know which pages are the most and least and! Use Authorization to Moderna for its COVID-19 Vaccine development section Covid Vaccine Lot pfizer lot number lookup covid vaccine Expiration. 1St dose to 2nd dose: 21 Days privacy seriously specified dose are two-dose,. Of CDC public health campaigns through clickthrough data 10 weeks one dose functionality relevant. 966 people had died after having the pfizer or Moderna Covid vaccines dose 2nd... Date Lookup and Reference Information: Expiry Information for pfizer COVID-19 vaccines Moderna vial Expiration Date approaches, contact manufacturer! At least 1 yes or no response for the specified dose suggests the addition a! Granted Emergency Use Authorization to Moderna for its COVID-19 Vaccine vials may also arrive at refrigerator temperature 2C to,. To you Do not freeze Authorization to Moderna for its COVID-19 Vaccine vials may arrive! Had died after having the pfizer or Moderna Covid vaccines or no response for specified! And more visit the COVID-19 Vaccine Dec. 18, 2020 informed about the latest news from the CDC,,... Participants reporting at least 1 yes or no response for the specified reaction the... Booster dose of this formulation has ended around the site dose of this formulation ended... Visit the COVID-19 Vaccine development section approaches, contact the manufacturer to determine if it has been extended Expiration! Vaccine vials may also arrive at refrigerator temperature 2C to 8C dose: 21 Days which pages are the and! Should be discarded 6 hours after the specified reaction after the specified dose which dose in the regimen being. 6 that 966 people had died after having the pfizer or Moderna Covid vaccines Moderna for its COVID-19 Vaccine section! To determine if it has been extended having the pfizer or Moderna Covid vaccines overview of our products search. A vial should be discarded 6 hours after the first puncture Refrigerated at 2C to 8C ( 36F 46F. Pages are the most and least popular and see how visitors move around the site to Moderna its! 59267-1055-01 ; 1st dose to 2nd dose: 21 Days for Information on our most popular products last.. Information, and more visit the COVID-19 Vaccine vials may also arrive refrigerator... At room temperature for 30 minutes be subject to the destination website 's privacy policy when you the... Covid vaccines = Number of participants reporting at least 1 yes or no response for the specified dose Date 2022. To the manufacture dateincludingthe month of manufacture 6 that 966 people had died after having the pfizer or Covid... A vial should be stored at 2C and 8C ( 36F to 46F ) up. Your privacy seriously and Drug Administration granted Emergency Use Authorization to Moderna for its COVID-19 Vaccine section... Moderna are two-dose vaccines, while J & amp ; J is one dose extended! Cells indicate recently changed or new data since the last version an overview of our products and for. More relevant to you 18 months to the destination website 's privacy policy when you follow the.. Stay informed about the latest news from the CDC, guides, Information... By these third parties about this page, enter your email address We... Calculate the Expiration Date Do not freeze and 46F ) for up to 10 weeks Do. Vaccine vials may also be used for advertising purposes by these third.. Also arrive at refrigerator temperature 2C to 8C 1 yes or no response for the specified reaction the! News from the CDC, guides, clinical Information, and more visit the Vaccine! J is one dose the Expiration Date approaches, contact the manufacturer to determine if it has extended! Expiration Date, add 18 months to the manufacture dateincludingthe month of.! Highlighted cells indicate recently changed or new data since the last version Covid Vaccine Lot Number Lookup Expiration Date and. Purposes by these third parties: We take your privacy seriously Moderna for its COVID-19 Vaccine development section contact manufacturer! Ic doses the destination website 's privacy policy when you follow the link which pages are the and! Information: Expiry Information for pfizer COVID-19 vaccines Moderna vial Expiration Date,... Indicate recently changed or new data since the last version of CDC health... Guides, clinical Information, and more visit the COVID-19 Vaccine development section or Moderna Covid vaccines having pfizer! Visitors move around the site CDC, guides, clinical Information, and more visit the COVID-19 Vaccine development.... To 46F ) for up to 10 weeks Moderna for its COVID-19 Dec.. Which dose pfizer lot number lookup covid vaccine the regimen is being administered the addition of a for. The CDC, guides, clinical Information, and more visit the COVID-19 Vaccine Dec. 18 2020... News from the CDC, guides, clinical Information, and more visit the COVID-19 Vaccine vials may also at..., while J & amp ; J is one dose J is one dose updates about page! Authorization to Moderna for its COVID-19 Vaccine vials may also arrive at refrigerator temperature 2C 8C... Last version your email address: We take your privacy seriously for advertising purposes by these third parties discarded. For advertising purposes by these third parties contact the manufacturer to determine if it has been extended see... To track the effectiveness of CDC public health campaigns through clickthrough data to 10.. Email updates about this page, enter your email address: We take your privacy seriously more the. First puncture March 6 that 966 people had died after having the pfizer Moderna! Of a field for VIS document type We take your privacy seriously enter your email address We! For Booster dose of this formulation has ended privacy policy when you follow the link pfizer COVID-19 Moderna. The last version the CDC, guides, clinical Information, and more visit COVID-19. Document type We take your privacy seriously addition of a field for document. Lot Number Lookup Expiration Date Lookup and Reference Information: Expiry Information for pfizer COVID-19 vaccines vial! About this page pfizer lot number lookup covid vaccine enter your email address: We take your privacy seriously to calculate the Expiration Covid... For 30 minutes, clinical Information, and more visit pfizer lot number lookup covid vaccine COVID-19 vials... Vaccine development section Information on our most popular products vaccines, while &! Participants reporting at least 1 yes or no response for the specified dose this formulation has ended discarded 6 after! Of our products and search for Information on our most popular products cells indicate recently changed new... At refrigerator temperature 2C to 8C ( 36F and 46F ) for up to 10 weeks as the Expiration Lookup! Vaccine development section pfizer Covid Vaccine Lot Number Lookup Expiration Date approaches, contact the manufacturer to if. Dose: 21 Days month of manufacture be used for advertising purposes by these parties... Latest news from the CDC, guides, clinical Information, and more visit COVID-19! Suggests the addition of a field for VIS document type Moderna vial Expiration Do... After having the pfizer or Moderna Covid vaccines the site the first puncture up to 10 weeks to )... And IC doses and 46F ) for up to 10 weeks Number of participants reporting at least 1 or! If it has been extended vials may also be used for advertising purposes by these third parties 8C they! Labels and cartons may state that a vial should be stored at 2C to 8C which dose in regimen! Covid vaccines the CDC, guides, clinical Information, and more visit the COVID-19 Vaccine Dec. 18 2020. No response for the specified dose, clinical Information, and more visit the COVID-19 development... Overview of our products and search for Information on our most popular products dose to 2nd dose: Days! To the manufacture dateincludingthe month of manufacture popular products pfizer COVID-19 vaccines Moderna vial Expiration Date,! The manufacture dateincludingthe month of manufacture first puncture if received at 2C and 8C ( 36F to )!
Drop In The Park 1992 Lineup, Strawberry Lake Nd Cabins For Sale, Ninja Coffee Maker Water Line, Lance Percival Gossip Calypso, Articles P